DENTSPLY SIRONA (XRAY) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

DENTSPLY SIRONA

NasdaqGS•Healthcare•Medical Instruments & Supplies

$11.38-0.05(<0.01%)Market closed

Market Cap

$2.07B

P/S

0.6x

P/B

1.5x

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

How this company scores

AverageMetricSide Score: 43/100

Strongest: Profitability (11/25); weakest: Balance Sheet & Red Flags (10/25).

Profitability11/25

Growth11/25

Balance Sheet & Red Flags10/25

Cash & Earnings Quality11/25

Strengths

Profit converts from growthImproving marginsNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 22.5x5y range 22.5x – 30.6x

Currently near its 4-quarter median.

P/S · 0.6x5y range 0.6x – 2.9x

Currently below its 20-quarter median.

P/B · 1.5x5y range 1.5x – 2.5x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

FCF consistently trails net income (avg 0.1x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume

Market Cap $2.07B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $3.64B
Q. Revenue: $898.00M
TTM EBITDA: $39.00M
TTM Op. Income: $-310.00M
Q. Op. Income: $82.00M
TTM Net Income: $-546.00M
Q. Net Income: $37.00M
EPS: $0.18
Shares Out.: $199.70M

$3.64B in TTM revenue declined 0.8% YoY, reaching $898.00M last quarter. TTM EBITDA of $39.00M and TTM operating income of $-310.00M show growth is flowing through to the bottom line. However, net income is negative at $546.00M — growth is not yet reaching the bottom line. Over the past year, TTM revenue is down 1% — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 54.9%
EBITDA Margin: 18.6%
Op. Margin: 9.1%
Net Margin: 4.1%

Op. margin of 9.1% is up 22.8% YoY — cost efficiency is improving. Net margin at 4.1% and gross margin of 54.9% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 3 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 0.6x
P/B Ratio: 1.5x

P/S of 0.6x and P/B of 1.5x. P/S is low relative to typical market levels.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $5.20B
Cash: $239.00M
Long-Term Debt: $2.00B
Book Value: $1.35B
D/E Ratio: 1.5
Debt/EBITDA: 12.0

With $5.20B in assets and $2.00B in long-term debt, D/E is 1.5and book value is $1.35B — moderate leverage. Over the past year, debt/equity is up 31% — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $99.00M
TTM Free Cash Flow: $143.00M
FCF Margin: 3.9%
FCF / Net Income: -0.3

TTM FCF of $143.00M on $99.00M in operating cash flow. The FCF / Net Income ratio of -0.3x means the business consumes cash — it is not yet self-funding. Over the past year, free cash flow is up 4% — an improving trend.